Safety
Octreotide
Adverse-event report summary for Octreotide, drawn from the FDA Adverse Event Reporting System (FAERS).
- Total reports
- 8,003
- Reports flagged serious
- 6,875
“Serious” is FAERS’s own report-level flag (e.g. death, hospitalization, or another outcome the reporter marked as serious) and does not indicate a verified or compound-caused outcome.
Most frequently reported reactions
- Off Label Use876 reports
- Diarrhoea843 reports
- Drug Ineffective837 reports
- Death582 reports
- Nausea579 reports
- Fatigue525 reports
- Abdominal Pain414 reports
- Malignant Neoplasm Progression390 reports
- Vomiting339 reports
- Product Use In Unapproved Indication324 reports
- Weight Decreased307 reports
- Dyspnoea300 reports
- Pain293 reports
- Asthenia287 reports
- Headache279 reports
Counts reflect the most-reported reaction terms (MedDRA preferred terms) associated with reports naming this compound. A single report can list multiple reactions, so reaction counts need not sum to the total number of reports.